YUVIDAP

Description

• Active Ingredient: Dapagliflozin 10 mg.
• Indications:
  • Management of type 2 diabetes mellitus
  • Improving glycemic control in adults with type 2 diabetes
  • Can be used as monotherapy or in combination with other antidiabetic medications
• Mechanism of Action: Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that works by blocking the reabsorption of glucose in the kidneys. This action promotes the excretion of excess glucose through urine, thereby reducing blood glucose levels.
• Benefits:
  • Improves glycemic control by reducing blood glucose levels.
  • Promotes weight loss and lowers blood pressure as additional benefits.
  • Can be used alone or in combination with other antidiabetic medications for better glycemic control.
  • Reduces the risk of cardiovascular events in patients with established cardiovascular disease.
• Precautions: Not recommended for individuals with a known hypersensitivity to dapagliflozin or any other components of the formulation. Use with caution in patients with a history of hypotension, renal impairment, or a history of urinary tract infections. It is contraindicated in patients with severe renal impairment, end-stage renal disease, or on dialysis. Regular monitoring of renal function and blood glucose levels is recommended. Consult a healthcare provider before using during pregnancy or breastfeeding.